Clinical trial
Randomized Placebo-controlled Trial of the Safety and Efficacy of Topical Sodium Metabisulfite for the Treatment of Calcinosis in Patients With Systemic Sclerosis.
NCT06155578 is registered in ClinicalTrials.gov with Pontificia Universidad Catolica de Chile as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Placebo-controlled Trial of the Safety and Efficacy of Topical Sodium Metabisulfite for the Treatment of Calcinosis in Patients With Systemic Sclerosis.
- Lead sponsor
- Pontificia Universidad Catolica de Chile
- Phase
- Phase 1/2
- Overall status
- Unknown status
- Start date
- January 2, 2024
- Completion date
- December 31, 2024
- Enrollment
- 20 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
calcinosis, systemic sclerosis